1.	Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper Gastrointestinal Cancer Surgery Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 900/429/1, NCT00790140
2.	Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 20 to 75 Sponsor: Other Protocol IDs: INCAN/CC/330/09, CA171/CB/558/09, NCT01048970
3.	Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery Patients Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: 11005, NCT01320319
4.	Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: Not specified Sponsor: Other Protocol IDs: EPACT, NCT01048463